Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas

Modern Pathology

Volumn 19, Issue 2, 2006, Pages 186-194

  Brandal, Petter ^a   Lie, Agnes Kathrine ^a   Bassarova, Assia ^a   Svindland, Aud ^b   Risberg, Bjørn ^a   Danielsen, Håvard ^a   Heim, Sverre ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Kidney; Mucinous tubular and spindle cell tumor; Numerical chromosome aberrations

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE REPORT; CENTROMERE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIPLOIDY; DISOMY; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERPHASE; KARYOTYPE; KIDNEY CARCINOMA; MALE; MONOSOMY; MUCINOUS CARCINOMA; NEPHRON; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA; TRIPLOIDY; TUMOR CELL; X CHROMOSOME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED, 80 AND OVER; CA-15-3 ANTIGEN; CARCINOMA; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; GENOME, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; KERATIN-7; KERATINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; VIMENTIN;

EID: 30944450960     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800499     Document Type: Article

References (22)

1. Otani M, Shimizu T, Serizawa H, et al. Low-grade renal cell carcinoma arising from the lower nephron: a case report with immunohistochemical, histochemical and ultrastructural studies. Pathol Int 2001;51:954-960.
2. Hes O, Hora M, Perez-Montiel DM, et al. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/ spindle and cuboidal renal cell carcinoma components. Histopathology 2002;41:549-555.
3. Lloreta J, Corominas JM, Munne A, et al. Low-grade spindle cell carcinoma of the kidney. Ultrastruct Pathol 1998;22:83-90.
4. He Q, Ohaki Y, Mori O, et al. A case report of renal cell tumor in a 45-year-old female mimicking lower portion nephrogenesis. Pathol Int 1998;48:416-420.
5. Srigley JR. Mucinous tubular and spindle cell carcinoma In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). Pathology & Genetics of Tumours of the Urinary System and Male Genital Organs 1st edn. IARC Press: Lyon, 2004, pp 40.
6. Kuroda N, Toi M, Hiroi M, et al. Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. Histol Histopathol 2005;20:221-224.
7. Meloni-Ehrig AM. Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 2002;115:164-172.
8. Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: newly recognised entities in the renal cell carcinoma family. Pathology 2003;35:499-504.
9. Rakozy C, Schmahl GE, Bogner S, et al. Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 2002;15:1162-1171.
10. Weber A, Srigley J, Moch H. Mucinous spindle cell carcinoma of the kidney. A molecular analysis. Pathologe 2003;24:453-459.
11. Sudbo J, Kildal W, Johannessen AC, et al. Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol 2002;20:456-462.
12. Mandahl N. Methods in solid tumors cytogenetics In: Rooney DE, Czepulkowski BH (eds). Human cytogenetics - a practical approach, Vol II, Malignancy and Acquired Abnormalities. IRL Press: Oxford, 1992, pp 155-187.
13. Mitelman F (ed). ISCN. An International System for Human Cytogenetic Nomenclature. S. Karger: Basel, 1995.
14. Micci F, Teixeira MR, Heim S. Complete cytogenetic characterization of the human breast cancer cell line MA11 combining G-banding, comparative genomic hybridization, multicolor fluorescence in situ hybridization, RxFISH, and chromosome-specific painting. Cancer Genet Cytogenet 2001;131:25-30.
15. Brandal P, Bjerkehagen B, Heim S. Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 2004;6:578-583.
16. Karhu R, Kahkonen M, Kuukasjarvi T, et al. Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization. Cytometry 1997;28:198-205.
17. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
18. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 1994;10:231-243.
19. Kraggerud SM, Szymanska J, Abeler VM, et al. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res 2000;60:3025-3030.
20. Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
21. Knuutila S, Nylund SJ, Wessman M, et al. Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology. Cancer Genet Cytogenet 1994;72:1-15.
22. Brandal P, Busund LT, Heim S. Chromosome abnormalities in juxtaglomerular cell tumors. Cancer 2005;104:504-510.